GHK Cu Dosage Questions From a Cosmetic Shelf to an Unlabeled Injection Vial
No injectable GHK Cu amount is established. A face cream has a real label, while a vial listing has none, and the human evidence is mostly small cream trials.
- Cosmetics need an ingredient list but no FDA approval, and make no dose claim.
- A 2026 review calls human GHK Cu evidence thin, mostly small face cream trials.
- FDA plans an advisory meeting on injectable GHK Cu before the end of February 2027.
On a store shelf GHK Cu appears as copper tripeptide-1 on a cosmetic label with a named company, but cosmetics are not approved by FDA before sale and the label states no clinical dose. Injectable vials have no label, and FDA notes a risk of immunogenicity for injectable GHK Cu. A cream study cannot support an injection amount, and an advisory panel before February 2027 would not set a dose either.